Inhibition of nitric oxide synthase-2 reduces the severity of mouse hepatitis virus-induced demyelination: Implications for NOS2/NO regulation of chemokine expression and inflammation

Journal of NeuroVirology

Volumn 5, Issue 1, 1999, Pages 48-54

  Lane, Thomas E ^a,b   Fox, Howard S ^a   Buchmeier, Michael J ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chemokines; Demyelination; Inflammation; MHV; Nitric oxide; Nitric oxide synthase

Indexed keywords

AMINOGUANIDINE; CHEMOKINE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; DEMYELINATING DISEASE; DISEASE SEVERITY; MORTALITY; MOUSE; MULTIPLE SCLEROSIS; MURINE HEPATITIS CORONAVIRUS; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RIBONUCLEASE PROTECTION ASSAY; SPINAL CORD; VIRUS ENCEPHALITIS;

ANIMALIA; CORONAVIRUS; MURINAE; MURINE HEPATITIS VIRUS;

EID: 0032892478     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550289909029745     Document Type: Article

References (35)

1. Adamus G, Machnicki M, Amundson D, Adlard K, Offner H (1997). Similar pattern of MCP-1 expression in spinal cords and eyes of Lewis rats with experimental autoimmune encephalomyelitis associated anterior uveitis. J Neurosci Res 50: 531-538.
2. Beckman JS (1996). Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol 9: 836-844.
3. Beckman JS, Koppenol WH (1996). Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271: C1424-C1437.
4. Berman J, Guida M, Warren J, Amat J, Brosnan C (1996). Localization of monocyte chemoattractant peptide-1 expression in the central nervous system in experimental autoimmune encephalomyelitis and trauma in the rat. J Immunol 156: 3017-3023.
5. Bo L, Dawson TM, Wesselingh S, Mork S, Choi S, Kong PA, Hanley D, Trapp BD (1994). Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann Neurol 36: 778-786.
6. Brenner T, Brocke S, Szafer F, Sobel RA, Parkinson JF, Perez DH, Steinman L (1997). Inhibition of nitric oxide synthese for treatment of experimental autoimmune encephalomyelitis. J Immunol 158: 2940-2946.
7. Compton SR, Barthold SW, Smith AL (1993). The cellular and molecular pathogenesis of coronaviruses. Lab Anim Sci 43: 15-28.
8. Cross AH, Misko T, Lin R, Hickey W, Trotter J, Tilton R (1994). Aminoguanidine, an inhibitor of nitric oxide synthase, ameliorates experimental autoimmune encephalomeylitis in SJL mice. J Clin Invest 93: 2684-2690.
9. Dalziel RG, Lampert PW, Talbot PJ, Buchmeier MJ (1986). Site-specific alteration of murinte hepatitis virus type 4 peplomer glycoprotein E2 results in reduced neurovirulence. J Virol 59: 463-471.
10. De Groot CJ, Ruuls SR, Theeuwes JW, Dijkstra CD, Van der Valk P (1997). Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions. J Neuropathol Exp Neurol 56: 10-20.
11. Giovannoni G, Heales SJR, Silver NC, Riordan JO, Miller RF, Land JM, Clark JB, Thompsom ET (1997). Raised serum nitrate and nitrite levels in patients with multiple sclerosis. J Neurol Sci 145: 77-81.
12. Glabinski A, Tani M, Aras S, Soler M, Tuohy V, Ransohoff R (1995). Regulation and function of central nervous system chemokines. Int J Devl Neuroscience 13: 153-165.
13. Glabinski AR, Tani M, Tuohy RM, Ransohoff RM (1997). Synchronous synthesis of alpha and beta chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis. Am J Pathol 150: 617-630.
14. Grzybicki D, Moore SA, Schelper R, Glabinski AR, Ransohoff RM, Murphy S (1998). Expression of monocyte chemoattractant protein (MCP-1) and nitric oxide synthase-2 following cerebral trauma. Acta Neuropathol (Berl) 95: 98-103.
15. Hayashi M, Luo Y, Laning J, Strieter RM, Dorf ME (1995). Production and function of monocyte chemoattractant protein-1 and other beta chemokines in murine glial cells. J Neuroimmunol 60: 143-150.
16. Hogaboam CM, Chensue SW, Steinhauser ML, Huffnagle GB, Lukacs NW, Strieter RM, Kunkel SL (1997). Alteration of the cytokine phenotype in an experimental lung granuloma model by inhibiting nitric oxide. J Immunol 159: 5585-5593.
17. Houtman JJ, Fleming JO (1996a). Pathogenesis of mouse hepatitis virus-induced demyelination. J Neurovirol 2: 361-376.
18. Houtman JJ, Fleming JO (1996b). Dissociation of demyelination and viral clearance in congenitally immunodeficient mice infected with murine coronavirus JHM. N Neurovirol 2: 101-110.
19. Kwon NS, Stuehr DJ, Nathan CF (1991). Inhibition of tumor ribonucleotide reductase by macrophage-derived nitric oxide. J Exp Med 174: 761-767.
20. Kyuwa S, Stohlman SA (1990). Pathogenesis of a neurotropic murine coronavirus, strain JHM in the central nervous system of mice. Sem Virol 1: 273-280.
21. Lane TE, Asensio VC, Yu N, Paoletti AD, Campbell IL, Buchmeier MJ (1998). Dynamic regulation of γ- and β-chemokine expression in the central nervous system during mouse hepatitis virus-induced demyelinating disease. J Immunol 160: 970-978.
22. Lane TE, Buchmeier MJ (1997). Murine coronavirus infection: a paradigm for virus-induced demyelinating disease. Trends in Microbiology 5: 9-14.
23. Lane TE, Paoletti AD, Buchmeier MJ (1997). Disassociation between the in vitro and in vivo effects of nitric oxide on a neurotropic m urine coronavirus. J Virol 71: 2202-2210.
24. Lavi E, Weiss SR (1989). Coronaviruses. In: Clinical and Molecular Aspects of Neurotropic Virus Infection. Gilden DH, Lipton HL, (eds). Kluwer Academic Publishers: Boston, pp 101-139.
25. Marcinkiewicz J, Grabowska A, Chain B (1995). Nitric oxide up-regulates the release of inflammatory mediators by mouse macrophage. Eur J Immunol 25: 947-951.
26. Merrill JE, Ignarro LJ, Sherman MP, Melinek J, Lane TE (1993). Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol 151: 2132-2141.
27. Merrill JE, Murphy SP (1997). Inflammatory events at the blood brain barrier: regulation of adhesion molecules, cytokines, and chemokines by reactive nitrogen and oxygen species. Brain, Behavior, and Immunity 11: 245-263.
28. Remick DG, Villarete L (1996). Regulation of cytokine gene expression by reactive oxygen and reactive nitrogen intermediates. J Leukoc Biol 59: 471-475.
29. Rose JW, Hill KE, Wada Y, Jurtz CI, Tsunoda I, Fujinami RS, Cross AH (1998). Nitric oxide synthase inhibitor, aminoguanidine, reduces inflammation and demyelination produced by Theiler's virus infection. J Neuroimmunol 81: 82-89.
30. Stuehr DJ, Nathan CF (1989). Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 169: 1543-1555.
31. Taub DD, Oppenheim JJ (1994). Chemokines, inflammation and the immune system. Therap Immunol 1: 229-246.
32. Taub DD, Proost P, Murphy WJ, Anver M, Longo DL, van Damme J, Oppenheim JJ (1995). Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. J Clin Invest 95: 1370-1376.
33. Sun N, Grzybicki D, Castro R, Murphy S, Perlman S (1995). Activation of astrocytes in the spinal cord of mice chronically infected with a neurotropic coronavirus. Virology 213: 482-493.
34. Wang F, Stohlman S, Fleming J (1990). Demyelination induced by murine hepatitis virus JHM (MHV-4) is immunologically mediated. J Neuroimmunol 30: 31-41.
35. Zhao W, Tilton RG, Corbett JA, McDaniel ML, Misko TP, Williamson JR, Cross AG, Hickey WF (1996). Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of nitric oxide synthase. J Neuroimmunol 64: 123-133.